LMR Partners LLP purchased a new position in Medical Properties Trust, Inc. (NYSE:MPW) during the second quarter, Holdings Channel reports. The fund purchased 337,672 shares of the real estate investment trust’s stock, valued at approximately $4,346,000.

A number of other hedge funds have also made changes to their positions in MPW. UBS Asset Management Americas Inc. boosted its position in Medical Properties Trust by 13.6% in the fourth quarter. UBS Asset Management Americas Inc. now owns 458,798 shares of the real estate investment trust’s stock worth $5,642,000 after buying an additional 54,835 shares during the last quarter. Macquarie Group Ltd. boosted its position in Medical Properties Trust by 3.9% in the fourth quarter. Macquarie Group Ltd. now owns 253,400 shares of the real estate investment trust’s stock worth $3,116,000 after buying an additional 9,400 shares during the last quarter. Raymond James Trust N.A. purchased a new position in Medical Properties Trust during the first quarter worth $154,000. Bank of Montreal Can boosted its position in Medical Properties Trust by 8.8% in the first quarter. Bank of Montreal Can now owns 44,122 shares of the real estate investment trust’s stock worth $568,000 after buying an additional 3,573 shares during the last quarter. Finally, Capstone Asset Management Co. boosted its position in Medical Properties Trust by 1.8% in the first quarter. Capstone Asset Management Co. now owns 29,540 shares of the real estate investment trust’s stock worth $381,000 after buying an additional 520 shares during the last quarter. 82.12% of the stock is owned by hedge funds and other institutional investors.

Shares of Medical Properties Trust, Inc. (NYSE MPW) opened at 12.67 on Tuesday. Medical Properties Trust, Inc. has a 52 week low of $11.54 and a 52 week high of $15.74. The firm has a market cap of $4.43 billion, a price-to-earnings ratio of 15.49 and a beta of 0.89. The firm has a 50 day moving average of $12.82 and a 200 day moving average of $13.04.

Medical Properties Trust (NYSE:MPW) last issued its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 earnings per share for the quarter, meeting the consensus estimate of $0.32. The business had revenue of $166.80 million for the quarter, compared to analyst estimates of $163.08 million. Medical Properties Trust had a net margin of 42.25% and a return on equity of 7.54%. The firm’s revenue was up 32.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 EPS. Equities analysts predict that Medical Properties Trust, Inc. will post $0.88 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “337,672 Shares in Medical Properties Trust, Inc. (MPW) Acquired by LMR Partners LLP” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/15/337672-shares-in-medical-properties-trust-inc-mpw-acquired-by-lmr-partners-llp.html.

Several equities analysts have recently commented on the stock. Royal Bank Of Canada reaffirmed a “buy” rating on shares of Medical Properties Trust in a research report on Monday, May 15th. ValuEngine cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $16.00 price target (up previously from $15.00) on shares of Medical Properties Trust in a research report on Friday, June 9th. BidaskClub raised shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Saturday, June 10th. Finally, Deutsche Bank AG increased their price target on shares of Medical Properties Trust from $13.50 to $15.00 and gave the stock a “buy” rating in a research report on Tuesday, July 4th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the company. Medical Properties Trust currently has a consensus rating of “Hold” and a consensus target price of $14.20.

In other Medical Properties Trust news, CFO R Steven Hamner sold 85,000 shares of the business’s stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.00% of the stock is owned by insiders.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Stock Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related stocks with our FREE daily email newsletter.